Society Letters

CDC Coalition Letter on FY22 Appropriations

November 30, 2021

Dear Chairwoman DeLauro, Chairman Leahy, Ranking Member Granger and Vice Chairman Shelby:

"The undersigned 140 members of the CDC Coalition and other supporting state and national organizations urge you to include at least the House-passed level of $10.5 billion for the Centers for Disease Control and Prevention’s programs in any final FY 2022 Labor, Health and Human Services, Education and Related Agencies appropriations bill. We truly appreciate your support for CDC and for the significant increases provided in both the House and Senate versions of the FY 2022 appropriations bill. Strong funding for CDC is critical to supporting all of CDC’s activities and programs, which are essential to protect the health of our communities. Due to years of underfunding, many CDC programs have not received the funding that is needed to address the many health challenges we face as a nation, resulting in many of CDC’s most effective prevention programs not reaching all states. We also believe that it is critical for Congress to quickly finalize the FY 2022 appropriations process to avoid lengthy continuing resolutions that bring uncertainty and make it more difficult for the agency and its grantees to protect the public’s health."

arrowRead the Full Letter

Last Updated:
Take Action

Make Your Voice Heard

We rely on your voice to advocate for our policy priorities. Join us to show our strength as a community that cares about endocrinology. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.

We rely on your voice to advocate for our policy priorities. Join us to show our strength as a community that cares about endocrinology. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.

Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.